These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 32386427)

  • 1. Early clinical markers of aggressive multiple sclerosis.
    Malpas CB; Manouchehrinia A; Sharmin S; Roos I; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Eichau S; Bergamaschi R; Sola P; Ferraro D; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Ozakbas S; Van Pesch V; Granella F; Hupperts R; Pucci E; Boz C; Sidhom Y; Gouider R; Spitaleri D; Soysal A; Petersen T; Verheul F; Karabudak R; Turkoglu R; Ramo-Tello C; Terzi M; Cristiano E; Slee M; McCombe P; Macdonell R; Fragoso Y; Olascoaga J; Altintas A; Olsson T; Butzkueven H; Hillert J; Kalincik T
    Brain; 2020 May; 143(5):1400-1413. PubMed ID: 32386427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    He A; Merkel B; Brown JWL; Zhovits Ryerson L; Kister I; Malpas CB; Sharmin S; Horakova D; Kubala Havrdova E; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T;
    Lancet Neurol; 2020 Apr; 19(4):307-316. PubMed ID: 32199096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
    Usta NC; Boz C; Terzi M
    Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
    Bose G; Healy BC; Saxena S; Saleh F; Paul A; Barro C; Lokhande HA; Polgar-Turcsanyi M; Anderson M; Glanz BI; Guttmann CRG; Bakshi R; Weiner HL; Chitnis T
    Mult Scler Relat Disord; 2023 Jun; 74():104695. PubMed ID: 37060852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.
    Hughes S; Spelman T; Trojano M; Lugaresi A; Izquierdo G; Grand'maison F; Duquette P; Girard M; Grammond P; Oreja-Guevara C; Hupperts R; Boz C; Bergamaschi R; Giuliani G; Rio ME; Lechner-Scott J; van Pesch V; Iuliano G; Fiol M; Verheul F; Barnett M; Slee M; Herbert J; Kister I; Vella N; Moore F; Petkovska-Boskova T; Shaygannejad V; Jokubaitis V; McDonnell G; Hawkins S; Kee F; Gray O; Butzkueven H;
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):305-10. PubMed ID: 22205675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Multiple Sclerosis Severity Score in a large US cohort.
    Santoro JD; Waltz M; Aaen G; Belman A; Benson L; Gorman M; Goyal MS; Graves JS; Harris Y; Krupp L; Lotze T; Mar S; Moodley M; Ness J; Rensel M; Rodriguez M; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Hurtubise BF; Roalstad S; Rose J; Casper TC; Chitnis T;
    Neurology; 2020 Sep; 95(13):e1844-e1853. PubMed ID: 32690790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K; Lawton M; Robertson N; Tremlett H; Zhu F; Harding K; Oger J; Ben-Shlomo Y
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
    Jokubaitis VG; Spelman T; Kalincik T; Lorscheider J; Havrdova E; Horakova D; Duquette P; Girard M; Prat A; Izquierdo G; Grammond P; Van Pesch V; Pucci E; Grand'Maison F; Hupperts R; Granella F; Sola P; Bergamaschi R; Iuliano G; Spitaleri D; Boz C; Hodgkinson S; Olascoaga J; Verheul F; McCombe P; Petersen T; Rozsa C; Lechner-Scott J; Saladino ML; Farina D; Iaffaldano P; Paolicelli D; Butzkueven H; Lugaresi A; Trojano M;
    Ann Neurol; 2016 Jul; 80(1):89-100. PubMed ID: 27145331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapses add to permanent disability in relapsing multiple sclerosis patients.
    Koch-Henriksen N; Sørensen PS; Magyari M
    Mult Scler Relat Disord; 2021 Aug; 53():103029. PubMed ID: 34116481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.
    Baroncini D; Simone M; Iaffaldano P; Brescia Morra V; Lanzillo R; Filippi M; Romeo M; Patti F; Chisari CG; Cocco E; Fenu G; Salemi G; Ragonese P; Inglese M; Cellerino M; Margari L; Comi G; Zaffaroni M; Ghezzi A;
    JAMA Neurol; 2021 Jun; 78(6):726-735. PubMed ID: 33938921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Predictors of 9-Year Disability in Pediatric Multiple Sclerosis.
    De Meo E; Bonacchi R; Moiola L; Colombo B; Sangalli F; Zanetta C; Amato MP; Martinelli V; Rocca MA; Filippi M
    Ann Neurol; 2021 May; 89(5):1011-1022. PubMed ID: 33598931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multiple sclerosis relapses on progression diminishes with time.
    Tremlett H; Yousefi M; Devonshire V; Rieckmann P; Zhao Y;
    Neurology; 2009 Nov; 73(20):1616-23. PubMed ID: 19890070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis.
    Healy BC; Engler D; Gholipour T; Weiner H; Bakshi R; Chitnis T
    J Neurol Sci; 2011 Apr; 303(1-2):109-13. PubMed ID: 21251671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time between expanded disability status scale (EDSS) scores.
    Zurawski J; Glanz BI; Chua A; Lokhande H; Rotstein D; Weiner H; Engler D; Chitnis T; Healy BC
    Mult Scler Relat Disord; 2019 May; 30():98-103. PubMed ID: 30763908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalization is associated with subsequent disability in multiple sclerosis.
    Garland A; Metz LM; Bernstein CN; Peschken CA; Hitchon CA; Marrie RA
    Mult Scler Relat Disord; 2017 May; 14():23-28. PubMed ID: 28619426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry.
    Kenney R; Liu M; Patil S; Alroughani R; Ampapa R; Bergamaschi R; Boz C; Butzkueven H; Gomez JC; Cartechini E; Madueño SE; Ferraro D; Grand-Maison F; Granella F; Horakova D; Izquierdo Ayuso G; Kalincik T; Lizrova Preiningerova J; Lugaresi A; Onofrj M; Ozakbas S; Patti F; Sola P; Soysal A; Spitaleri DLA; Terzi M; Turkoglu R; van Pesch V; Saidha S; Thorpe LE; Galetta SL; Balcer LJ; Kister I; Spelman T;
    J Neurol Sci; 2021 Nov; 430():118067. PubMed ID: 34537678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.